EVQLV

EVQLV

Biotechnology

New York, NY 1,448 followers

Leveraging advances in computation to revolutionize the design and development of therapeutic antibodies

About us

EVQLV leverages advances in computation to revolutionize the design and development of therapeutic antibodies. We work with partners at the discovery stage to accelerate the speed of antibody discovery. For those collaborators who have preclinical, clinical, or commercial assets, we support the optimization of antibody candidates, develop assets that expand IP protection, and design next generation and innovative immunotherapies. All of our work is performed at accelerated speeds and scale only feasible by leveraging computational tools that learn from massive and diverse datasets.

Industry
Biotechnology
Company size
2-10 employees
Headquarters
New York, NY
Type
Privately Held
Founded
2019
Specialties
AI Designed Antibodies

Locations

Employees at EVQLV

Updates

Similar pages

Browse jobs

Funding

EVQLV 6 total rounds

Last Round

Non equity assistance
See more info on crunchbase